世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035962

血液グループ化試薬の世界市場(2023-2027)

TechNavio

Global Blood-Grouping Reagents Market 2023-2027

発刊日 2023/07/05

言語英語

体裁PDF/167ページ

ライセンス/価格167ページ

0000035962

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

血液グループ化試薬市場は、2022年から2027年の間に4億5,695万米ドル、予測期間中のCAGRは7.73%で成長すると予測されています。血液グループ化試薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、慢性疾患の有病率の増加、献血の増加、輸血と血液型タイピングの需要の増加が牽引しています。

調査範囲

  • 市場セグメント
    ➣ エンドユーザー別
      ◇ 病院と血液銀行
      ◇ 臨床検査室
      ◇ 学術研究機関
    ➣ 技術別
      ◇ PCR・マイクロアレイ技術
      ◇ アッセイ技術
      ◇ 超並列シーケンス技術
      ◇ 血清学
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、今後数年間の血液グループ化試薬市場の成長を促進する主な理由の一つとして、ソーシャルメディアマーケティングの出現を挙げています。また、技術の進歩やヘルスケア施設の普及が進むことで、同市場では大きな需要が見込まれます。

血液グループ化試薬市場に関するレポートは、次の分野をカバーしています。

  • 血液グループ化試薬市場の規模
  • 血液グループ化試薬市場の予測
  • 血液グループ化試薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Alpha Laboratories
    ➣ Arena Bio Scien
    ➣ Atlas Medical GmbH, AXO Science
    ➣ BAG Diagnostics GmbH
    ➣ Bio Rad Laboratories Inc.
    ➣ Danaher Corp.
    ➣ DIAGAST SAS
    ➣ Grifols SA
    ➣ Haemokinesis Ltd.
    ➣ Merck KGaA
    ➣ Mesa Laboratories Inc.
    ➣ Novacyt SA
    ➣ QuidelOrtho Corp.
    ➣ Quotient Ltd.
    ➣ Rapid Labs Ltd.
    ➣ Torax Biosciences Ltd.
    ➣ Tulip Diagnostics Pvt. Ltd.
    ➣ Werfenlife SA
    ➣ Calibre Scientific Inc.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technique
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global blood-grouping reagents m 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global blood-grouping reagents m 2017 - 2021 ($ million)
4.2 End-User Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
4.3 Technique Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Technique Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals and blood banks - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
6.4 Clinical laboratories - Market size and forecast 2022-2027
Exhibit 38: Chart on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Clinical laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Clinical laboratories - Year-over-year growth 2022-2027 (%)
6.5 Academic and research institutes - Market size and forecast 2022-2027
Exhibit 42: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Technique
7.1 Market segments
Exhibit 48: Chart on Technique - Market share 2022-2027 (%)
Exhibit 49: Data Table on Technique - Market share 2022-2027 (%)
7.2 Comparison by Technique
Exhibit 50: Chart on Comparison by Technique
Exhibit 51: Data Table on Comparison by Technique
7.3 PCR-based and microarray techniques - Market size and forecast 2022-2027
Exhibit 52: Chart on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
7.4 Assay-based techniques - Market size and forecast 2022-2027
Exhibit 56: Chart on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Assay-based techniques - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Assay-based techniques - Year-over-year growth 2022-2027 (%)
7.5 Massively parallel sequencing techniques - Market size and forecast 2022-2027
Exhibit 60: Chart on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
7.6 Serology - Market size and forecast 2022-2027
Exhibit 64: Chart on Serology - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Serology - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Serology - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Serology - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Technique
Exhibit 68: Market opportunity by Technique ($ million)
Exhibit 69: Data Table on Market opportunity by Technique ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Alpha Laboratories
Exhibit 119: Alpha Laboratories - Overview
Exhibit 120: Alpha Laboratories - Product / Service
Exhibit 121: Alpha Laboratories - Key offerings
12.4 Arena Bio Scien
Exhibit 122: Arena Bio Scien - Overview
Exhibit 123: Arena Bio Scien - Product / Service
Exhibit 124: Arena Bio Scien - Key offerings
12.5 Atlas Medical GmbH
Exhibit 125: Atlas Medical GmbH - Overview
Exhibit 126: Atlas Medical GmbH - Product / Service
Exhibit 127: Atlas Medical GmbH - Key offerings
12.6 Bio Rad Laboratories Inc.
Exhibit 128: Bio Rad Laboratories Inc. - Overview
Exhibit 129: Bio Rad Laboratories Inc. - Business segments
Exhibit 130: Bio Rad Laboratories Inc. - Key news
Exhibit 131: Bio Rad Laboratories Inc. - Key offerings
Exhibit 132: Bio Rad Laboratories Inc. - Segment focus
12.7 Danaher Corp.
Exhibit 133: Danaher Corp. - Overview
Exhibit 134: Danaher Corp. - Business segments
Exhibit 135: Danaher Corp. - Key news
Exhibit 136: Danaher Corp. - Key offerings
Exhibit 137: Danaher Corp. - Segment focus
12.8 DIAGAST SAS
Exhibit 138: DIAGAST SAS - Overview
Exhibit 139: DIAGAST SAS - Product / Service
Exhibit 140: DIAGAST SAS - Key offerings
12.9 Grifols SA
Exhibit 141: Grifols SA - Overview
Exhibit 142: Grifols SA - Business segments
Exhibit 143: Grifols SA - Key offerings
Exhibit 144: Grifols SA - Segment focus
12.10 Haemokinesis Ltd.
Exhibit 145: Haemokinesis Ltd. - Overview
Exhibit 146: Haemokinesis Ltd. - Product / Service
Exhibit 147: Haemokinesis Ltd. - Key offerings
12.11 Merck KGaA
Exhibit 148: Merck KGaA - Overview
Exhibit 149: Merck KGaA - Business segments
Exhibit 150: Merck KGaA - Key news
Exhibit 151: Merck KGaA - Key offerings
Exhibit 152: Merck KGaA - Segment focus
12.12 Novacyt SA
Exhibit 153: Novacyt SA - Overview
Exhibit 154: Novacyt SA - Business segments
Exhibit 155: Novacyt SA - Key offerings
Exhibit 156: Novacyt SA - Segment focus
12.13 QuidelOrtho Corp.
Exhibit 157: QuidelOrtho Corp. - Overview
Exhibit 158: QuidelOrtho Corp. - Product / Service
Exhibit 159: QuidelOrtho Corp. - Key offerings
12.14 Quotient Ltd.
Exhibit 160: Quotient Ltd. - Overview
Exhibit 161: Quotient Ltd. - Product / Service
Exhibit 162: Quotient Ltd. - Key news
Exhibit 163: Quotient Ltd. - Key offerings
12.15 Rapid Labs Ltd.
Exhibit 164: Rapid Labs Ltd. - Overview
Exhibit 165: Rapid Labs Ltd. - Product / Service
Exhibit 166: Rapid Labs Ltd. - Key offerings
12.16 Tulip Diagnostics Pvt. Ltd.
Exhibit 167: Tulip Diagnostics Pvt. Ltd. - Overview
Exhibit 168: Tulip Diagnostics Pvt. Ltd. - Product / Service
Exhibit 169: Tulip Diagnostics Pvt. Ltd. - Key offerings
12.17 Werfenlife SA
Exhibit 170: Werfenlife SA - Overview
Exhibit 171: Werfenlife SA - Product / Service
Exhibit 172: Werfenlife SA - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Technique
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global blood-grouping reagents m 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Technique Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinical laboratories - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinical laboratories - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Technique - Market share 2022-2027 (%)
Exhibits49: Data Table on Technique - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Technique
Exhibits51: Data Table on Comparison by Technique
Exhibits52: Chart on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Assay-based techniques - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Assay-based techniques - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Serology - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Serology - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Serology - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Serology - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Technique ($ million)
Exhibits69: Data Table on Market opportunity by Technique ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Alpha Laboratories - Overview
Exhibits120: Alpha Laboratories - Product / Service
Exhibits121: Alpha Laboratories - Key offerings
Exhibits122: Arena Bio Scien - Overview
Exhibits123: Arena Bio Scien - Product / Service
Exhibits124: Arena Bio Scien - Key offerings
Exhibits125: Atlas Medical GmbH - Overview
Exhibits126: Atlas Medical GmbH - Product / Service
Exhibits127: Atlas Medical GmbH - Key offerings
Exhibits128: Bio Rad Laboratories Inc. - Overview
Exhibits129: Bio Rad Laboratories Inc. - Business segments
Exhibits130: Bio Rad Laboratories Inc. - Key news
Exhibits131: Bio Rad Laboratories Inc. - Key offerings
Exhibits132: Bio Rad Laboratories Inc. - Segment focus
Exhibits133: Danaher Corp. - Overview
Exhibits134: Danaher Corp. - Business segments
Exhibits135: Danaher Corp. - Key news
Exhibits136: Danaher Corp. - Key offerings
Exhibits137: Danaher Corp. - Segment focus
Exhibits138: DIAGAST SAS - Overview
Exhibits139: DIAGAST SAS - Product / Service
Exhibits140: DIAGAST SAS - Key offerings
Exhibits141: Grifols SA - Overview
Exhibits142: Grifols SA - Business segments
Exhibits143: Grifols SA - Key offerings
Exhibits144: Grifols SA - Segment focus
Exhibits145: Haemokinesis Ltd. - Overview
Exhibits146: Haemokinesis Ltd. - Product / Service
Exhibits147: Haemokinesis Ltd. - Key offerings
Exhibits148: Merck KGaA - Overview
Exhibits149: Merck KGaA - Business segments
Exhibits150: Merck KGaA - Key news
Exhibits151: Merck KGaA - Key offerings
Exhibits152: Merck KGaA - Segment focus
Exhibits153: Novacyt SA - Overview
Exhibits154: Novacyt SA - Business segments
Exhibits155: Novacyt SA - Key offerings
Exhibits156: Novacyt SA - Segment focus
Exhibits157: QuidelOrtho Corp. - Overview
Exhibits158: QuidelOrtho Corp. - Product / Service
Exhibits159: QuidelOrtho Corp. - Key offerings
Exhibits160: Quotient Ltd. - Overview
Exhibits161: Quotient Ltd. - Product / Service
Exhibits162: Quotient Ltd. - Key news
Exhibits163: Quotient Ltd. - Key offerings
Exhibits164: Rapid Labs Ltd. - Overview
Exhibits165: Rapid Labs Ltd. - Product / Service
Exhibits166: Rapid Labs Ltd. - Key offerings
Exhibits167: Tulip Diagnostics Pvt. Ltd. - Overview
Exhibits168: Tulip Diagnostics Pvt. Ltd. - Product / Service
Exhibits169: Tulip Diagnostics Pvt. Ltd. - Key offerings
Exhibits170: Werfenlife SA - Overview
Exhibits171: Werfenlife SA - Product / Service
Exhibits172: Werfenlife SA - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations

この商品のレポートナンバー

0000035962

TOP